Fred Hutchinson Cancer Center
Clinical trials sponsored by Fred Hutchinson Cancer Center, explained in plain language.
-
Blood cancer transplant study tests safer GVHD prevention
Disease control TerminatedThis phase 2 trial tested two different drug combinations to prevent graft-versus-host disease (GVHD) in 150 people with blood cancers receiving a stem cell transplant from an unrelated donor. Both combinations used cyclosporine and sirolimus, plus either mycophenolate mofetil or…
Phase: PHASE2 • Sponsor: Fred Hutchinson Cancer Center • Aim: Disease control
Last updated Jun 22, 2026 11:56 UTC
-
Can an antiviral drug help ICU patients breathe easier?
Prevention TerminatedThis study tested whether the antiviral drug ganciclovir could prevent the reactivation of cytomegalovirus (CMV) in adults with sepsis and acute respiratory failure in the ICU. The goal was to see if the drug could increase the number of days patients were free from breathing sup…
Phase: PHASE3 • Sponsor: Fred Hutchinson Cancer Center • Aim: Prevention
Last updated Jun 01, 2026 18:06 UTC
-
New hope for frail patients after stem cell transplant: supportive care combo tested
Symptom relief TerminatedThis study tested two approaches—supportive and palliative care (focusing on stress and symptom relief) and clinical management of other health problems (like heart or lung disease through exercise, diet, and medication)—to see if they could improve quality of life and survival a…
Phase: PHASE2, PHASE3 • Sponsor: Fred Hutchinson Cancer Center • Aim: Symptom relief
Last updated Jun 22, 2026 12:09 UTC